+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Nalmefene"

Narcotic Drugs Global Market Report 2024 - Product Thumbnail Image

Narcotic Drugs Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Opioid related disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Opioid related disorder - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
From
Drug Overdose - Pipeline Review, H2 2020 - Product Thumbnail Image

Drug Overdose - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 79 Pages
  • Global
From
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Nalmefene is a drug used to treat addiction disorders, such as alcohol and opioid dependence. It is an opioid receptor antagonist, meaning it blocks the effects of opioids on the brain. It is taken orally and is available in both tablet and injection form. Nalmefene works by reducing cravings and decreasing the amount of alcohol consumed. It is also used to reduce the risk of relapse in those who have already stopped drinking. Nalmefene is a relatively new drug, having been approved by the US Food and Drug Administration in 2014. It is currently available in many countries, including the United States, Canada, the United Kingdom, and Australia. The market for nalmefene is growing, as more people are seeking treatment for addiction disorders. It is becoming increasingly popular as a treatment option due to its effectiveness and safety profile. Some companies in the nalmefene market include Lundbeck, Orexo, and Indivior. Show Less Read more